Doyle Anthony (CIK 0001808688)

Latest company ownership

Shares held
250,100
Last filed at
Dec 23, 2024
Confidence Score
50.1
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 19, 2024 Dec 23, 2024 BIOCRYST PHARMACEUTICALS INC CFO Sell 91.3 +118,239 45.54% ✗ $18.2K
Dec 14, 2024 Dec 17, 2024 BIOCRYST PHARMACEUTICALS INC CFO Sell 42.5 -7,890 -2.95% ✗ $59.4K
May 14, 2024 May 15, 2024 BIOCRYST PHARMACEUTICALS INC CFO Buy 95.0 +36,300 15.75% ✗ $202.2K
Dec 19, 2023 Dec 20, 2023 BIOCRYST PHARMACEUTICALS INC CFO Sell 46.3 -2,482 -1.08% ✗ $15K
Dec 14, 2023 Dec 18, 2023 BIOCRYST PHARMACEUTICALS INC CFO Sell 91.3 +28,525 14.16% ✗ $35.2K
Dec 15, 2022 Dec 19, 2022 BIOCRYST PHARMACEUTICALS INC CFO Sell 37.5 -5,700 -3.36% ✓ $62.1K
Nov 23, 2021 Nov 24, 2021 BIOCRYST PHARMACEUTICALS INC CFO Buy 97.5 +35,258 60.31% ✗ $440K
Aug 11, 2020 Aug 12, 2020 BIOCRYST PHARMACEUTICALS INC CFO Buy 95.0 +54,000 100.00% ✗ $220.3K